As of 2024-12-15, the Relative Valuation of Pulmonx Corp (LUNG) is (26.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.10 USD, the upside of Pulmonx Corp based on Relative Valuation is -528.5%.
The range of the Relative Valuation is (22.41) - (23.14) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 25.7x | 20.4x |
| Forward P/E multiples | 15.5x - 16.0x | 15.8x |
| Fair Price | (22.41) - (23.14) | (26.14) |
| Upside | -467.5% - -479.3% | -528.5% |
| Date | P/E |
| 2024-12-13 | -4.22 |
| 2024-12-12 | -4.18 |
| 2024-12-11 | -4.42 |
| 2024-12-10 | -4.55 |
| 2024-12-09 | -4.40 |
| 2024-12-06 | -4.43 |
| 2024-12-05 | -4.26 |
| 2024-12-04 | -4.51 |
| 2024-12-03 | -4.57 |
| 2024-12-02 | -4.52 |
| 2024-11-29 | -4.46 |
| 2024-11-27 | -4.36 |
| 2024-11-26 | -4.47 |
| 2024-11-25 | -4.57 |
| 2024-11-22 | -4.70 |
| 2024-11-21 | -4.44 |
| 2024-11-20 | -4.29 |
| 2024-11-19 | -4.15 |
| 2024-11-18 | -4.23 |
| 2024-11-15 | -4.38 |
| 2024-11-14 | -4.46 |
| 2024-11-13 | -4.65 |
| 2024-11-12 | -4.86 |
| 2024-11-11 | -5.22 |
| 2024-11-08 | -5.14 |
| 2024-11-07 | -5.09 |
| 2024-11-06 | -5.33 |
| 2024-11-05 | -4.92 |
| 2024-11-04 | -4.92 |
| 2024-11-01 | -4.34 |
| 2024-10-31 | -4.32 |
| 2024-10-30 | -4.70 |
| 2024-10-29 | -4.68 |
| 2024-10-28 | -4.29 |
| 2024-10-25 | -4.17 |
| 2024-10-24 | -4.21 |
| 2024-10-23 | -4.24 |
| 2024-10-22 | -4.24 |
| 2024-10-21 | -4.32 |
| 2024-10-18 | -4.49 |
| 2024-10-17 | -4.43 |
| 2024-10-16 | -4.70 |
| 2024-10-15 | -4.81 |
| 2024-10-14 | -4.74 |
| 2024-10-11 | -4.61 |
| 2024-10-10 | -4.46 |
| 2024-10-09 | -4.72 |
| 2024-10-08 | -4.56 |
| 2024-10-07 | -4.85 |
| 2024-10-04 | -5.05 |